Vireo Growth (VREOF) Inventory Average (2021 - 2026)
Vireo Growth (VREOF) posted Inventory Average of $68.0 million for Q1 2026, up 19.49% sequentially from $57.0 million in Q4 2025, and up 202.38% YoY from $22.5 million in Q1 2025.
Vireo Growth (VREOF) Inventory Average (2021 - 2026) Analysis & Trends
Vireo Growth has reported Inventory Average for 6 years, with the latest figure at $68.0 million in Q1 2026.
- Quarterly Inventory Average rose 202.38% year-over-year to $68.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $68.0 million (up 202.38% YoY) and the FY2025 annual result came in at $40.8 million, up 99.42% from the prior year.
- Inventory Average rose to $68.0 million in Q1 2026 per VREOF's latest filing, from $57.0 million in the prior quarter.
- Over five years, Inventory Average peaked at $68.0 million in Q1 2026 and troughed at $18.4 million in Q2 2022.
- A 5-year average of $28.6 million and a median of $20.0 million in 2024 frame the typical range for Inventory Average.
- The sharpest annual moves came in 2024 and 2026: Inventory Average dropped 8.77% in 2024, then jumped 202.38% in 2026.
- Over 5 years, Inventory Average stood at $19.8 million in 2022, then dropped by 3.23% to $19.2 million in 2023, then increased by 8.27% to $20.8 million in 2024, then surged by 174.38% to $57.0 million in 2025, then gained by 19.49% to $68.0 million in 2026.
- According to Business Quant data, Inventory Average over the past three periods registered $68.0 million, $57.0 million, and $58.5 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inventory Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.65 Bn | 42.68 Bn | - | 1.41 Bn |
| 2 | Teva Pharmaceutical Industries | 43.09 Bn | 39.44 Bn | 2.15 Bn | 3.20 Bn |
| 3 | Zoetis | 31.54 Bn | 29.86 Bn | 1.05 Bn | 2.56 Bn |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | 8.99 Bn |
| 5 | United Therapeutics | 22.11 Bn | 19.45 Bn | 683.80 Mn | 186.05 Mn |
| 6 | Viatris | 18.77 Bn | 17.88 Bn | 1.46 Bn | 3.93 Bn |
| 7 | Neurocrine Biosciences | 15.62 Bn | 15.23 Bn | 935.80 Mn | 84.35 Mn |
| 8 | Elanco Animal Health | 12.07 Bn | 11.54 Bn | 798.00 Mn | 1.74 Bn |
| 9 | Dr Reddys Laboratories | 10.09 Bn | 9.93 Bn | - | 824.00 Mn |
| 10 | Vireo Growth | 492.35 Mn | 350.05 Mn | 95.30 Mn | 112.75 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 68.05 Mn |
| Dec 31, 2025 | 56.95 Mn |
| Sep 30, 2025 | 58.47 Mn |
| Jun 30, 2025 | 43.19 Mn |
| Mar 31, 2025 | 22.50 Mn |
| Dec 31, 2024 | 20.76 Mn |
| Sep 30, 2024 | 19.97 Mn |
| Jun 30, 2024 | 19.72 Mn |
| Mar 31, 2024 | 19.32 Mn |
| Dec 31, 2023 | 19.17 Mn |
| Sep 30, 2023 | 19.42 Mn |
| Jun 30, 2023 | 20.82 Mn |
| Mar 31, 2023 | 21.18 Mn |
| Dec 31, 2022 | 19.81 Mn |
| Sep 30, 2022 | 18.86 Mn |
| Jun 30, 2022 | 18.43 Mn |
| Mar 31, 2022 | 19.34 Mn |
| Dec 31, 2021 | 20.28 Mn |
| Sep 30, 2021 | 18.43 Mn |
| Jun 30, 2021 | 15.63 Mn |